Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bladder cancer
bladder cancer
Taris Biomedical closes enrollment in phase Ib trial for drug-device combo
Mass Device
Sat, 01/7/17 - 12:07 pm
Taris
drug-device combos
devices
gemcitabine
bladder cancer
Your attention, please: AstraZeneca asks for a moment of rapt silence, for a BLA acceptance?
Endpoints
Sun, 12/11/16 - 11:57 am
AstraZeneca
durvalumab
anti-PD-L1
bladder cancer
Heat Biologics stock active on heels of lung, bladder cancer results
Bizjournals.com
Tue, 12/6/16 - 10:07 pm
Heat Biologics
lung cancer
bladder cancer
HS-110
vaccines
Bristol’s Opdivo Has One Eye on Advanced Bladder Cancer
Market Realist
Tue, 11/22/16 - 11:29 am
Bristol-Myers Squibb
Opdivo
bladder cancer
Sanofi Shuts Down Bladder Cancer Drug Production: Inevitable Drug Shortage To Harm Patients
Forbes
Sat, 11/19/16 - 11:25 am
Sanofi
bladder cancer
drug shortages
BCG
Merck's Keytruda succeeds in key bladder cancer trial
Yahoo/Reuters
Fri, 10/21/16 - 09:58 am
Merck
Keytruda
bladder cancer
clinical trials
Merck's Keytruda posts 24% response rate in PhII bladder cancer study
Fierce Pharma
Mon, 10/10/16 - 09:09 am
Merck
Keytruda
bladder cancer
Bristol-Myers Squibb Co Wins a Sixth Breakthrough Tag for Opdivo
Bidness, ETC
Tue, 06/28/16 - 05:23 pm
Bristol-Myers Squibb
Opdivo
breakthrough therapies
bladder cancer
FDA
Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation
Marketwatch
Mon, 06/27/16 - 10:28 am
Bristol-Myers Squibb
bladder cancer
breakthrough therapies
FDA
Opdivo
New Roche med Tecentriq shines in study of untreated bladder cancer patients
Fierce Pharma
Sun, 06/5/16 - 11:52 am
Roche
Tecentriq
bladder cancer
ASCO 2016
FDA approves Roche therapy for bladder cancer
Marketwatch
Thu, 05/19/16 - 09:55 am
FDA
Roche
bladder cancer
Tecentriq
atezolizumab
Roche's new PD-L1 bladder cancer drug could be on the market by September
Fierce Biotech
Tue, 03/15/16 - 10:35 pm
Roche
PD-L1
bladder cancer
atezolizumab
Reeling from an FDA rejection, Telesta sheds 15% of its staff
Fierce Biotech
Thu, 03/10/16 - 10:52 am
FDA
Telesta
layoffs
MCNA
bladder cancer
AstraZeneca wins FDA breakthrough status for key cancer drug
Yahoo/Reuters
Wed, 02/17/16 - 10:32 am
AstraZeneca
FDA
breakthrough status
durvalumab
bladder cancer
anti-PD-L1
Roche's star immunotherapy posts positive results in bladder cancer
Fierce Biotech
Sat, 01/9/16 - 10:36 am
Roche
immunotherapy
bladder cancer
atezolizumab
Durham's Heat reaches 'significant milestone' for bladder cancer drug
Bizjournals.com
Fri, 10/9/15 - 10:30 am
bladder cancer
Heat Biologics
clinical trials
HS-410
Roche says new drug shows benefits in lung, bladder cancer tests
Yahoo/Reuters
Sun, 09/27/15 - 08:47 pm
Roche
lung cancer
bladder cancer
atezolizumab
Hunting an FDA cancer drug OK and a partner, little Telesta raises $28M
Fierce Biotech
Thu, 08/20/15 - 02:51 pm
FDA
Telesta
bladder cancer
Takeda Actos settlement seems shaky as plaintiffs give it the sniff test
Fierce Pharma
Fri, 08/14/15 - 11:17 am
Takeda
Actos
diabetes
bladder cancer
Takeda Offers $2.2 Billion to Settle Actos Drug Cases
Yahoo/Bloomberg
Wed, 04/1/15 - 08:38 am
Takeda
Actos
diabetes
bladder cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »